Arrowhead Pharmaceuticals Inc.

+0.35 (+0.54%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.85B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$42.19 Million
Adjusted EPS$0.05
See more estimates
10-Day MA$64.61
50-Day MA$64.69
200-Day MA$72.79
See more pivots

Arrowhead Pharmaceuticals Inc. Stock, NASDAQ:ARWR

177 East Colorado Boulevard, Suite 700, Pasadena, California 91105
United States of America
Phone: +1.626.304.3400
Number of Employees: 232


Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.